Literature DB >> 16049290

Association of chronic fatigue syndrome with human leucocyte antigen class II alleles.

J Smith1, E L Fritz, J R Kerr, A J Cleare, S Wessely, D L Mattey.   

Abstract

BACKGROUND: A genetic component to the development of chronic fatigue syndrome (CFS) has been proposed, and a possible association between human leucocyte antigen (HLA) class II antigens and chronic fatigue immune dysfunction has been shown in some, but not all, studies. AIMS: To investigate the role of HLA class II antigens in CFS.
METHODS: Forty nine patients with CFS were genotyped for the HLA-DRB1, HLA-DQA1, and HLA-DQB1 alleles and the frequency of these alleles was compared with a control group comprising 102 normal individuals from the UK. All patients and controls were from the same region of England and, apart from two patients, were white.
RESULTS: Analysis by 2 x 2 contingency tables revealed an increased frequency of HLA-DQA1*01 alleles in patients with CFS (51.0% v 35%; odds ratio (OR), 1.93; p = 0.008). HLA-DQB1*06 was also increased in the patients with CFS (30.2% v 20.0%; OR, 1.73, p = 0.052). Only the association between HLA-DQA1*01 and CFS was significant in logistic regression models containing HLA-DQA1*01 and HLA-DRQB1*06, and this was independent of HLA-DRB1 alleles. There was a decreased expression of HLA-DRB1*11 in CFS, although this association disappeared after correction for multiple comparisons.
CONCLUSIONS: CFS may be associated with HLA-DQA1*01, although a role for other genes in linkage disequilibrium cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049290      PMCID: PMC1770867          DOI: 10.1136/jcp.2004.022681

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

Review 1.  Could TCR antagonism explain associations between MHC genes and disease?

Authors:  Stanislav Vukmanović; Thomas A Neubert; Fabio R Santori
Journal:  Trends Mol Med       Date:  2003-04       Impact factor: 11.951

Review 2.  A systematic review and critical evaluation of the immunology of chronic fatigue syndrome.

Authors:  Marc Lyall; Mark Peakman; Simon Wessely
Journal:  J Psychosom Res       Date:  2003-08       Impact factor: 3.006

3.  No association of HLA class II antigens in chronic fatigue syndrome.

Authors:  D Middleton; D A Savage; D G Smith
Journal:  Dis Markers       Date:  1991 Jan-Feb       Impact factor: 3.434

4.  Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome.

Authors:  R H Keller; J L Lane; N Klimas; W M Reiter; M A Fletcher; F van Riel; R Morgan
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

5.  Chronic fatigue syndrome: new evidence for a central fatigue disorder.

Authors:  Evelina Georgiades; Wilhelmina M H Behan; Liam P Kilduff; Marios Hadjicharalambous; Eileen E Mackie; John Wilson; Susan A Ward; Yannis P Pitsiladis
Journal:  Clin Sci (Lond)       Date:  2003-08       Impact factor: 6.124

6.  Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis.

Authors:  B H Natelson; J J LaManca; T N Denny; A Vladutiu; J Oleske; N Hill; M T Bergen; L Korn; J Hay
Journal:  Am J Med       Date:  1998-09-28       Impact factor: 4.965

7.  Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome.

Authors:  Ralph D Levinson; Min S Park; Sarah M Rikkers; Elaine F Reed; Justine R Smith; Tammy M Martin; James T Rosenbaum; C Stephen Foster; Mark D Sherman; Gary N Holland
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

8.  HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.

Authors:  Kati Karell; Andrew S Louka; Simon J Moodie; Henry Ascher; Fabienne Clot; Luigi Greco; Paul J Ciclitira; Ludvig M Sollid; Jukka Partanen
Journal:  Hum Immunol       Date:  2003-04       Impact factor: 2.850

9.  Consideration of narcolepsy in the differential diagnosis of chronic fatigue syndrome.

Authors:  A Ambrogetti; L G Olson
Journal:  Med J Aust       Date:  1994-04-04       Impact factor: 7.738

Review 10.  The genetics of narcolepsy.

Authors:  Dorothee Chabas; Shahrad Taheri; Corinne Renier; Emmanuel Mignot
Journal:  Annu Rev Genomics Hum Genet       Date:  2003       Impact factor: 8.929

View more
  15 in total

Review 1.  A systematic review of the association between fatigue and genetic polymorphisms.

Authors:  Tengteng Wang; Jie Yin; Andrew H Miller; Canhua Xiao
Journal:  Brain Behav Immun       Date:  2017-01-12       Impact factor: 7.217

Review 2.  Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter?

Authors:  Esther Crawley; George Davey Smith
Journal:  Arch Dis Child       Date:  2007-09-05       Impact factor: 3.791

3.  A gene signature for post-infectious chronic fatigue syndrome.

Authors:  John W Gow; Suzanne Hagan; Pawel Herzyk; Celia Cannon; Peter O Behan; Abhijit Chaudhuri
Journal:  BMC Med Genomics       Date:  2009-06-25       Impact factor: 3.063

Review 4.  Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis.

Authors:  Stefania Fulle; Tiziana Pietrangelo; Rosa Mancinelli; Raoul Saggini; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2008-02-15       Impact factor: 2.698

5.  Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  K A Schlauch; S F Khaiboullina; K L De Meirleir; S Rawat; J Petereit; A A Rizvanov; N Blatt; T Mijatovic; D Kulick; A Palotás; V C Lombardi
Journal:  Transl Psychiatry       Date:  2016-02-09       Impact factor: 6.222

Review 6.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

7.  Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study.

Authors:  Melanie Perez; Rajeev Jaundoo; Kelly Hilton; Ana Del Alamo; Kristina Gemayel; Nancy G Klimas; Travis J A Craddock; Lubov Nathanson
Journal:  Front Pediatr       Date:  2019-05-24       Impact factor: 3.418

8.  Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.

Authors:  Tiago Dias Domingues; Anna D Grabowska; Ji-Sook Lee; Jose Ameijeiras-Alonso; Francisco Westermeier; Carmen Scheibenbogen; Jacqueline M Cliff; Luis Nacul; Eliana M Lacerda; Helena Mouriño; Nuno Sepúlveda
Journal:  Front Med (Lausanne)       Date:  2021-07-05

9.  The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem.

Authors:  Jonathan C W Edwards; Simon McGrath; Adrian Baldwin; Mark Livingstone; Andrew Kewley
Journal:  Fatigue       Date:  2016-04-28

10.  Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.

Authors:  Ingrid G Rekeland; Alexander Fosså; Asgeir Lande; Irini Ktoridou-Valen; Kari Sørland; Mari Holsen; Karl J Tronstad; Kristin Risa; Kine Alme; Marte K Viken; Benedicte A Lie; Olav Dahl; Olav Mella; Øystein Fluge
Journal:  Front Med (Lausanne)       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.